Latest filing published 06 Sept 2017 for Aevi Genomic Medicine, LLC, €84k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Philip R. Harper: trading record in brief
This profile gathers the share dealings of Philip R. Harper across 2 companies, led by American Capital, Ltd and Aevi Genomic Medicine, LLC. We count 30 filings; the first trade dates from 16 February 2006 and the latest from 1 September 2017.
Both buying and selling appear: 21 purchases worth €12.7M, against 7 sales worth €5.6M. Purchases outweigh sales by €7.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2017 alone, the filings show 7 purchases and no sales.
A typical purchase (the median) is worth €160k. The 7 purchases reviewed show no overlap with other insiders buying the same stock within a month.
Most recently, on 6 September 2017, the filings show an open-market purchase worth €84k in Aevi Genomic Medicine, LLC. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Philip R. Harper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 83,775 shares@ US$1.204.5% of flowCommon StockSEC:0001235802-17-000145:0Canonical exit: 30 Nov 2017 (T+90)
- 4,661 shares@ US$1.200.3% of flowCommon StockSEC:0001235802-17-000143:0Canonical exit: 20 Nov 2017 (T+90)
- 5,700 shares@ US$1.200.3% of flowCommon StockSEC:0001235802-17-000143:1Canonical exit: 21 Nov 2017 (T+90)
- 20,470 shares@ US$1.191.1% of flowCommon StockSEC:0001235802-17-000140:0Canonical exit: 8 Nov 2017 (T+90)
- 1,000,000 shares@ US$1.7989.1% of flowCommon StockSEC:0001686266-17-000002:0Canonical exit: 20 Jun 2017 (T+90)
- 4,705 shares@ US$1.600.4% of flowCommon StockSEC:0001686266-17-000002:1Canonical exit: 21 Jun 2017 (T+90)
- 53,826 shares@ US$1.604.3% of flowCommon StockSEC:0001686266-17-000002:2Canonical exit: 22 Jun 2017 (T+90)
- 930,762 sharesCommon StockSEC:0000899243-17-000359:0
- 12,747 sharesCommon StockSEC:0000899243-17-000359:1
- 70,000 shares@ US$15.31Common StockSEC:0001181073-15-000002:0
- 39,391 shares@ US$14.65Common StockSEC:0001181073-15-000001:0
- 43,600 shares@ US$14.72Common StockSEC:0001181073-14-000006:0
- 120,000 shares@ US$15.51Common StockSEC:0001181073-14-000004:0
- 60,000 shares@ US$15.25Common StockSEC:0001181073-14-000003:0
- 120,000 shares@ US$15.63Common StockSEC:0001181073-14-000002:0
- 15,000 shares@ US$14.76Common StockSEC:0001181073-13-000001:0
- 20,000 shares@ US$8.65Common StockSEC:0001181073-11-000001:0Canonical exit: 8 Sept 2011 (T+90)
- 40,000 shares@ US$5.14Common StockSEC:0001181073-10-000001:0Canonical exit: 16 Nov 2010 (T+90)
- 30,900 shares@ US$0.885Common StockSEC:0001181073-09-000002:0Canonical exit: 11 Jun 2009 (T+90)
- 350,000 shares@ US$0.61Common StockSEC:0001181073-09-000001:0Canonical exit: 4 Jun 2009 (T+90)
- 10,000 shares@ US$4.64Common StockSEC:0001181073-08-000003:0Canonical exit: 18 Feb 2009 (T+90)
- 9,000 shares@ US$5.79Common StockSEC:0001181073-08-000002:0Canonical exit: 11 Feb 2009 (T+90)
- 47,840 shares@ US$20.86Common StockSEC:0001181073-08-000001:0Canonical exit: 4 Dec 2008 (T+90)
- 50,000 shares@ US$43.38Common StockSEC:0001181073-07-000005:0Canonical exit: 5 Jun 2007 (T+90)
- 50,000 shares@ US$41.23Common StockSEC:0001181073-07-000004:0Canonical exit: 3 Jun 2007 (T+90)
25 of 29 declarations